# Award #75N93026D00021

Long-Term IDV Award to Utah State University for Antimicrobial Research

**Buyer:** National Institutes of Health

**Award Amount:** $2,500.00
**Ceiling:** $2,500.00

**Awarded:** September 30, 2026
**Period of Performance:** Sep 30, 2026 - Sep 29, 2036

**Identifier:** 75N93026D00021
**NAICS:** 541714

This indefinite delivery vehicle (IDV) contract was awarded to Utah State University, a leading public research university known for its expertise in microbiology and biochemistry. The contract focuses on the in vitro assessment of antimicrobial activity, supporting critical research that advances healthcare and pharmaceutical development. This long-term agreement ensures sustained laboratory evaluations of antimicrobial effectiveness, generating valuable data to aid drug development and regulatory decisions. Awarded through a competitive process, the contract reflects the agency's commitment to fostering scientific innovation over a multi-year period. With a decade-long performance period, the contract lays the foundation for ongoing, significant research efforts in antimicrobial treatments.

### Description

IN VITRO ASSESSMENT OF ANTIMICROBIAL ACTIVITY (IVAAA)

[View original record](https://www.usaspending.gov/award/CONT_IDV_75N93026D00021_7529)